Evidence map›Paper›PMID 39649234›Full record

ArticleCureus2024

Spontaneous Intramuscular Haematomas: A Single-Centre Retrospective Study and Proposed Management Algorithm.

Malin Gunawardena, Abubaker Elamin

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Malin GunawardenaGeneral Surgery, Università degli Studi di Milano, Milan, ITA.
Abubaker ElaminGeneral Surgery, Humanitas University, Milan, ITA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpontaneous intramuscular haematomas by definition are haematomas without known etiology and exclude those caused by trauma, surgery, and muscular disease. This is a rare condition which has been increasing in incidence lately largely due to anticoagulant therapy use and currently, there is no level 1 evidence with regards to the best management of these patients, with different institutions using different approaches to treatment. MATERIALS AND

methodsWe retrospectively analyzed 31 patients who were treated with the diagnosis of spontaneous intramuscular haematoma in our center, in the years between 2013 and 2017. Patient information was recorded including patient characteristics, vital parameters, biochemical data, imaging data, risk stratification scores, and patient outcomes.

resultsWe observed that on average males had longer hospitalizations and a higher baseline platelet count was a protective factor against haemorrhage. On temporal evaluation of haemoglobin levels, we saw an important drop of haemoglobin at T6 for the transfused patients. The majority of patients (61.29%) were treated with arterial embolization, with great technical and clinical success (94% and 81% respectively). There was also a very strong association between patients treated with non-operative therapy (NOT) and shorter hospitalization.  Conclusion: NOT and embolization therapy are very effective treatments for spontaneous haematomas in the appropriate patient and should be included in the protocol. The small sample size was a very large limitation for the study, and a multicentric study is needed to further strengthen any associations we saw between risk factors and outcomes. We propose the need to perform a prospective study to ascertain the appropriate follow-up times for such investigations.

Indexed as

acute abdominal surgeryiliopsoas hematomainterventional radiology guided embolizationspontaneous rectus sheath hematomaspontaneous retroperitoneal hematoma

Identifiers

PMID39649234
PMCPMC11625457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.